Detailed Information
Cited 0 time in 
Cited 2 time in 
Cited 2 time in
Metadata Downloads
Letrozol (Femara(R)) 호르몬 요법 후 발생한 방사선 회상 피부염A case of radiation recall dermatitis after hormonal therapy of letrozol (Femara®)
- Authors
- Ahn, J.Y.; Kim, J.Y.; Seo, S.J.; Hong, C.K.; Song, K.Y.
- Issue Date
- Jan-2006
- Publisher
- 대한피부과학회
- Keywords
- Letrozol (Femara®); Radiation recall dermatitis
- Citation
- Korean Journal of Dermatology, v.44, no.1, pp 83 - 85
- Pages
- 3
- Journal Title
- Korean Journal of Dermatology
- Volume
- 44
- Number
- 1
- Start Page
- 83
- End Page
- 85
- ISSN
- 0494-4739
- Abstract
- Radiation recall dermatitis gap (RRD) is the development of an inflammatory reaction throughout a previously irradiated area, precipitated by the administration of certain drugs. Usually chemotherapeutic agents have been associated with RRD, but other drugs reported include tamoxifen, Interferon alfa-2b, simvastatin, and antituberculous drugs. We present a case of RRD after chemotherapy with letrozol (Femara®). Letrozol is a third generation aromatase inhibitor, which acts as an anti-estrogen agent. This is the first reported case of RRD triggered by letrozol.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.